HUMAN COMBINATION VACCINES MARKET ANALYSIS

Market Challenges And Opportunities

Global Human Combination Vaccines Market: Restraints

Threat of bioterrorism and stringent regulatory policies for the approval of novel combination vaccine are the major restraints to the global human combination vaccine market. Bioterrorism refers to the use of biological agents such as bacteria, fungus, and virus to disrupt human life. Since these biological agents are unpredictable it is difficult to control them. Bioterrorism can easily spread through the route of vaccines hence, regulatory authorities scrutinise the vaccine development process to avoid any mishaps. For instance, the U.S Food and Administration authority has been directed by the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 to protect the public against bioweapons associated with vaccines, diagnostic tools, and drugs in the U.S. The U.S. FDA has set out a complex and multistep process for assessing the safety, efficiency, and immunogenicity of the vaccine before approval of licensure for a particular vaccine, followed by post-approval surveillance.  

Some combinations of vaccines are associated with unfavourable side effects which hinder human combination vaccine market growth. For instance, in 2020, the Com-Cov study led by the University of Oxford, U.K revealed that when doses of AstraZeneca and Pfizer COVID-19 vaccines were mixed a higher proportion of the users experienced side effects such as fever, fatigue, and headache.

Moreover, factors such as lack of awareness, poor healthcare infrastructure, and facilities in low and middle income countries such as India, Nigeria, Vietnam, and Brazil hinder the market growth of human combination vaccines. For instance, according to a survey by the World health Organisation in 2018, approximately 19.4 million paediatric population of the world was not vaccinated in recommended immunization schedule and amongst this 60% population was reported to be from low and middle income countries such as Pakistan, India, Indonesia, etc.